What causes Tetralogy of Fallot?

Tetralogy of Fallot (ToF) is a complex congenital heart defect that arises from abnormal development of the heart during early fetal life. The root cause lies in how certain parts of the heart’s structure form and align before birth, leading to four key anatomical abnormalities that define this condition.

At its core, Tetralogy of Fallot results from an abnormal positioning and growth pattern of the conal septum — a part of the heart’s outflow tract that separates blood flow destined for the lungs from blood going to the body. Normally, this septum grows straight down between two major arteries: the pulmonary artery (leading to lungs) and the aorta (leading to systemic circulation). In ToF, however, this septum deviates upward and forward (anterosuperior deviation), which disrupts normal alignment[3].

This misalignment causes four distinct defects:

1. **Ventricular Septal Defect (VSD):** A hole between the right and left ventricles allows oxygen-poor blood to mix with oxygen-rich blood.

2. **Pulmonary Stenosis:** Narrowing at or below the pulmonary valve restricts blood flow from right ventricle to lungs.

3. **Overriding Aorta:** The aorta is positioned directly over both ventricles instead of just over left ventricle, receiving mixed blood.

4. **Right Ventricular Hypertrophy:** Thickening of muscular wall in right ventricle due to increased workload pumping against obstruction.

The exact reasons why this conal septum shifts abnormally are multifactorial but largely involve genetic influences combined with environmental factors affecting embryonic cardiac development[1][4].

From a genetic perspective, multiple genes regulate how cells grow, migrate, and differentiate during formation of cardiac structures in early pregnancy. Mutations or disruptions in these genes can interfere with signaling pathways essential for proper morphogenesis—the process by which tissues take shape into functional organs[1]. For example:

– Genes like *TBX20* play critical roles as transcription factors controlling gene expression patterns needed for normal heart formation; altered expression or mutations here have been linked specifically with Tetralogy of Fallot[7].

– Other genes involved include those regulating neural crest cell migration—a group vital for forming parts like outflow tracts—and any disruption can lead to conotruncal anomalies such as ToF[5].

Environmental influences also contribute risks during pregnancy:

– Maternal infections such as rubella

– Exposure to harmful substances including alcohol or certain medications

– Poorly controlled diabetes in mother

These factors may affect fetal development either by direct toxicity or by altering gene expression through epigenetic mechanisms—changes that switch genes on/off without altering DNA sequence itself[4].

In addition, some cases arise sporadically without clear family history but still reflect complex interactions between inherited susceptibility and prenatal environment.

The developmental timeline is crucial: The heart begins forming very early after conception when cells destined for different chambers must migrate precisely and fuse correctly. If secondary fields contributing cells fail to integrate properly into primary cardiac structures—such as improper fusion/migration seen in secondary heart field—it leads commonly to complex defects including ToF[5]. This failure disturbs not only structural alignment but also affects valve formation and vessel connections critical for efficient circulation after birth.

Because these abnormalities reduce pulmonary blood flow while allowing mixing through VSD, infants often experience cyanosis (“blue baby syndrome”) due to insufficient oxygenation—a hallmark clinical sign prompting diagnosis soon after birth.

Understanding what causes Tetralogy of Fallot involves appreciating it as a disorder rooted deeply in embryology where genetic programming meets environmental exposures influencing cellular behavior during critical windows shaping cardiovascular anatomy. Advances continue revealing new molecular players responsible for these developmental errors offering hope toward better diagnosis through genetics counseling and potential future therapies targeting underlying mechanisms rather than just surgical correction alone.